ESMO 2022 Conference Coverage
Playback speed
10 seconds
ESMO 2022 on the IPSOS Phase 3 Study: 1L Atezo vs. Single-Agent Chemo in Patients With NSCLC Not Eligible for a Platinum-Containing Regimen
By
ESMO 2022 Conference Coverage
FEATURING
Siow Ming Lee
By
ESMO 2022 Conference Coverage
FEATURING
Siow Ming Lee
71 views
September 30, 2022
Comments 0
Login to view comments.
Click here to Login
Lung